510(k) K852986
K852986 is an FDA 510(k) premarket notification submitted by Clinical Technology Corp. for the device "GLYCO-SEP/ALC TEST KIT FOR SEPARAT OF HEMOGLOBIN". The FDA issued a decision of Substantially Equivalent on August 19, 1985. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Clinical Technology Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 19, 1985
- Date Received
- July 15, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type